Can Shorter TB Prevention Regimens Work?

• by Julia Cipriano, MS, CMPP

• March 23, 2026

The 18-Month MDR-TB Regimen Has a Successor

Six months, all-oral, better tolerated—and the infrastructure to make it work.

• by Kerri Miller

• April 16, 2026

• 3 min

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes

• by Kathryn Wighton

• April 21, 2026

• 2 min

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.

• by Andrea Surnit

• May 5, 2026

• 5 min